| α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson’s disease PM Levine, A Galesic, AT Balana, AL Mahul-Mellier, MX Navarro, ... Proceedings of the National Academy of Sciences 116 (5), 1511-1519, 2019 | 184 | 2019 |
| O-GlcNAcylation of α-synuclein at serine 87 reduces aggregation without affecting membrane binding YE Lewis, A Galesic, PM Levine, CA De Leon, N Lamiri, CK Brennan, ... ACS chemical biology 12 (4), 1020-1027, 2017 | 95 | 2017 |
| O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein PM Levine, CA De Leon, A Galesic, A Balana, NP Marotta, YE Lewis, ... Bioorganic & medicinal chemistry 25 (18), 4977-4982, 2017 | 35 | 2017 |
| Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein … YE Lewis, T Abeywardana, YH Lin, A Galesic, MR Pratt ACS chemical biology 11 (4), 931-942, 2016 | 32 | 2016 |
| Ubiquitination can change the structure of the α-synuclein amyloid fiber in a site selective fashion SP Moon, AT Balana, A Galesic, A Rakshit, MR Pratt The Journal of organic chemistry 85 (3), 1548-1555, 2019 | 25 | 2019 |
| Comparison of N-Acetyl-Glucosamine to Other Monosaccharides Reveals Structural Differences for the Inhibition of α-Synuclein Aggregation A Galesic, A Rakshit, G Cutolo, RP Pacheco, AT Balana, SP Moon, ... ACS chemical biology 16 (1), 14-19, 2021 | 23 | 2021 |
| Design and Characterization of a Zn2+-Binding Four-Helix Bundle Protein in the Biophysical Chemistry Laboratory BJ Stockman, JS Asheld, PJ Burburan, A Galesic, Z Nawlo, KF Sikorski Journal of chemical education 91 (3), 451-454, 2014 | 10 | 2014 |
| In vivo experimental and analytical studies for bevacizumab diffusion coefficient measurement in the rabbit vitreous humor S Zhang, A Penkova, MS Humayun, JC Martinez-Camarillo, AC Tadle, ... Journal of Heat Transfer 143 (3), 032101, 2021 | 5 | 2021 |
| Investigating the Effects of O-GlcNAc Modifications in Parkinson’s Disease Using Semisynthetic α-Synuclein A Galesic, MR Pratt Expressed Protein Ligation: Methods and Protocols, 313-326, 2020 | 5 | 2020 |
| Bevacizumab diffusion coefficient in vivo measurement of rabbit vitreous humor with fluorescein labeling AN Penkova, JC Martinez, M Humayun, A Tadle, A Galesic, A Calle, ... Investigative Ophthalmology & Visual Science 60 (9), 6103-6103, 2019 | 5 | 2019 |
| Combining non-canonical amino acid mutagenesis and native chemical ligation for multiply modifying proteins: A case study of α-synuclein post-translational modifications A Galesic, B Pan, J Ramirez, E Rhoades, MR Pratt, EJ Petersson Methods 218, 101-109, 2023 | | 2023 |
| O-GlcNAc modification alters alpha-synuclein aggregation and neuronal toxicity A Galesic, P Levine, AJ Balana, M Pratt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Functional analysis of O-GlcNAc modified alpha-synuclein using synthetic protein chemistry A Galesic, P Levine, A Balana, M Pratt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
| Preparation and Characterization of 15 N-labeled Desulfovibrio vulgaris Flavodoxin in the Presence of Macromolecular Crowding Agents Using 2D H-15 N NMR Spectroscopy A Galesic 2013 NCUR, 2013 | | 2013 |
